Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

The Fight Against Cholesterol Heats Up; FDA Panel Considers Drugs from Regeneron, Amgen Next Week
Barron's
Fri, 06/5/15 - 12:22 pm
Tags:
FDA, advisory panels, Regeneron, Sanofi, Amgen, PCSK9 inhibitors, Praluent
Galapagos leases one-third of Sanofi-founded biopark to consolidate French R&D operations
Fierce Biotech
Fri, 06/5/15 - 09:22 am
Tags:
R&D, Galapagos, Sanofi, France
FDA staff: Sanofi/Regeneron drug lowers LDL; is well tolerated
Yahoo/Reuters
Fri, 06/5/15 - 09:20 am
Tags:
FDA, Sanofi, Regeneron, alirocumab, advisory panels
FDA grants breathrough therapy designation to Genzyme's Olipudase Alfa
Yahoo/Reuters
Thu, 06/4/15 - 11:51 am
Tags:
Genzyme, FDA, olipudase alfa, Sanofi, Niemann-Pick disease
Who's best at connecting with 'worried well' millennials? J&J, Sanofi and UCB
Fierce Pharma Marketing
Mon, 06/1/15 - 07:08 pm
Tags:
millennials, JNJ, UCB Pharma, Sanofi
What To Expect When Afrezza Goes Direct To Consumer
Seeking Alpha
Mon, 06/1/15 - 12:19 pm
Tags:
Afrezza, DTC, diabetes, inhaled insulin, MannKind, Sanofi
For The Pricing Of New Cholesterol Lowering PCSK-9 Drugs, Does Dose Size Matter?
Forbes
Mon, 06/1/15 - 12:16 pm
Tags:
PCSK9 inhibitors, drug pricing, Amgen, Sanofi, Regeneron, Pfizer
Merck KGaA poaches Sanofi oncology exec Zhen Su
Fierce Biotech
Fri, 05/29/15 - 12:18 pm
Tags:
Merck KGaA, Sanofi, oncology
5 Drugs That Could Be Summer Blockbusters
Investors.com
Wed, 05/27/15 - 11:06 am
Tags:
Valeant Pharmaceuticals, Actavis, Xifaxan, Orkambi, Vertex Pharmaceuticals, Regeneron, Sanofi, Amgen, Repatha, eluxadoline, Praluent
Retrophin Turns Asklepion Voucher Into $245M Sanofi Payday
Xconomy
Wed, 05/27/15 - 09:52 am
Tags:
Retrophin, review vouchers, Sanofi, Asklepion Pharmaceuticals, FDA
The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war
Fierce Biotech
Tue, 05/26/15 - 04:52 pm
Tags:
Gilead Sciences, PCSK9 inhibitors, Amgen, Sanofi, Regeneron, drug pricing, Repatha, Praluent
Sanofi buys into NeuroVive's cardio drug in Korea
Fierce Biotech
Tue, 05/26/15 - 12:05 pm
Tags:
Sanofi, NeuroVive, Korea, CicloMulsion
Fight over hot new cholesterol drugs may be won in milligrams
Yahoo/Reuters
Tue, 05/26/15 - 09:37 am
Tags:
Amgen, Repatha, Regeneron, Sanofi, Praluent
Amgen's PCSK9 cholesterol game-changer could beat Sanofi's to an EU approval
BioPharma Dive
Thu, 05/21/15 - 08:47 am
Tags:
Amgen, PCSK9 inhibitor, Repatha, Europe, Sanofi, Regeneron, Praluent
Sanofi/Regeneron reports glowing phase 2b results for versatile asthma hopeful
BioPharma Dive
Wed, 05/20/15 - 06:18 pm
Tags:
Sanofi, Regeneron, dupilumab, asthma
Regeneron speeds toward the FDA with its would-be asthma blockbuster
Fierce Biotech
Mon, 05/18/15 - 09:56 pm
Tags:
Regeneron, FDA, asthma, dupilumab, Sanofi
CEO Pay Row at Sanofi AGM
In-Pharma Technologist
Mon, 05/18/15 - 09:03 am
Tags:
Sanofi, executive pay, Olivier Brandicourt, Chris Viehbacher
MannKind: Afrezza's slow start due to delays not demand for inhalable insulin
In-Pharma Technologist
Sun, 05/17/15 - 01:33 pm
Tags:
MannKind, Afrezza, diabetes, insulin, inhaled insulin, Sanofi
Sanofi moving forward on Celiac disease immunotherapy development
BioPharma Dive
Thu, 05/14/15 - 11:04 am
Tags:
Sanofi, celiac disease, R&D, Selecta Biosciences
MannKind: Marketing glitches, delays explain slow Afrezza uptake
BioPharma Dive
Wed, 05/13/15 - 11:27 am
Tags:
MannKind, Sanofi, diabetes, Afrezza, inhaled insulin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.